A new working group will be convened by the federal Industry department to connect and promote Australia’s emerging RNA sector and make it a bigger part of a $158...
The Australian biotech sector is at an “inflection point” and is ready to work with the federal government on its Future Made in Australia plan, and other critical policies,...
More than a decade after its introduction, the research and development tax incentive has been “life-changing” for Australia’s biotech industry and an example of how effective long-term consistent policy...
The Research and Development Tax Incentive is estimated to have generated $9.1 billion in economic activity in the Australian biotech sector in the decade to 2021, according to analysis...
Industry bodies have cautiously welcomed Industry and Science minister Ed Husic’s eight appointments to National Reconstruction Fund board, with some reserving judgement until details on the investment mandate are...
Helping companies see the benefit of being commonly understood is the essence of ensuring a comparable environmental, social and governance (ESG) practice for biotechs and medtechs. This provided the...
Life sciences industry representative body AusBiotech has launched a 10-year strategy for the biotechnology sector in an effort to “herald an era of Australian discovery, translationa and innovation”. The...
The federal government’s “enhanced” reforms to the research and development tax incentive passed Parliament just days after being announced, ending two and a half years of uncertainty for those...
Crucial research and thousands of jobs are at risk because the Australian biotech industry has been largely locked out of the federal government’s COVID-19 support efforts, according to AusBiotech....
The federal government’s “ill-informed” reforms to the research and development tax incentive will damage Australia’s burgeoning life sciences sector at a time when it is at the forefront of...